Hard NAPLEX Pain Management Practice Questions

Mastering pain management is a critical component of the NAPLEX Prep process, as it requires a deep understanding of equianalgesic dosing, opioid safety, and multi-modal therapeutic strategies. Candidates must be able to navigate complex clinical scenarios involving chronic pain, palliative care, and acute postoperative management while ensuring patient safety and regulatory compliance.

Concept Explanation

NAPLEX pain management focuses on the pharmacological treatment of various pain types through the use of non-opioid analgesics, opioids, and adjuvant medications. Effective pain management relies on the World Health Organization (WHO) analgesic ladder, which progresses from non-opioids like NSAIDs and acetaminophen to potent Mu-opioid receptor agonists. A core competency for the exam is performing equianalgesic conversions, which involve calculating equivalent doses when switching between different opioid medications or routes of administration. This process requires applying a cross-tolerance reduction (usually 25-50%) to ensure safety during the transition. Furthermore, pharmacists must understand the management of opioid-induced side effects, such as constipation (OIC), and the clinical application of antagonists like naloxone for overdose reversal. According to the Centers for Disease Control and Prevention (CDC), providing naloxone education is a standard of care for patients on high-dose opioid therapy.

Solved Examples

1. Equianalgesic Conversion: A patient is currently taking morphine sulfate IR 30 mg every 4 hours. The physician wants to switch the patient to oral hydromorphone. Calculate the equivalent daily dose of hydromorphone, assuming a 25% dose reduction for cross-tolerance. (Equianalgesic ratio: 30 mg oral morphine = 7.5 mg oral hydromorphone).
   1. Calculate the total daily dose (TDD) of morphine: $$30 \text{ mg} \times 6 \text{ doses/day} = 180 \text{ mg/day}$$
   2. Set up the ratio to find the hydromorphone equivalent: $$\frac{30 \text{ mg morphine}}{7.5 \text{ mg hydromorphone}} = \frac{180 \text{ mg morphine}}{X \text{ mg hydromorphone}}$$
   3. Solve for X: $$X = \frac{180 \times 7.5}{30} = 45 \text{ mg hydromorphone/day}$$
   4. Apply the 25% cross-tolerance reduction: $$45 \text{ mg} \times 0.75 = 33.75 \text{ mg hydromorphone/day}$$
2. Fentanyl Patch Calculation: A patient is receiving a continuous morphine IV infusion at 5 mg/hr. The team wants to transition the patient to a transdermal fentanyl patch. (Equianalgesic ratio: 10 mg IV morphine = 100 mcg/hr fentanyl patch).
   1. Calculate the TDD of IV morphine: $$5 \text{ mg/hr} \times 24 \text{ hours} = 120 \text{ mg/day}$$
   2. Convert IV morphine to oral morphine (Ratio 1:3): $$120 \text{ mg IV} \times 3 = 360 \text{ mg oral morphine/day}$$
   3. Use the standard conversion table (often provided on NAPLEX) where 60 mg/day oral morphine ≈ 25 mcg/hr fentanyl: $$\frac{360 \text{ mg/day}}{60 \text{ mg/day}} \times 25 \text{ mcg/hr} = 150 \text{ mcg/hr}$$
3. Methadone Dosing Logic: Why is methadone dosing uniquely challenging compared to other opioids?
   1. Methadone has a highly variable half-life (ranging from 8 to 59 hours), leading to potential accumulation and delayed respiratory depression.
   2. It is a substrate of multiple CYP450 enzymes (3A4, 2B6, 2C19), making it prone to significant drug-drug interactions.
   3. It can cause QTc prolongation, requiring baseline and periodic ECG monitoring.

Practice Questions

Test your skills with these hard NAPLEX pain management practice questions. For more calculation-heavy practice, you may also find our Hard NAPLEX Dosage Calculation Practice Questions helpful.

1. A 65-year-old male with bone metastasis is taking OxyContin 60 mg PO Q12H. His pain is poorly controlled, and he uses oxycodone IR 15 mg for breakthrough pain approximately 4 times a day. Calculate his total daily dose (TDD) of oxycodone in mg.
2. A patient is being switched from IV morphine (TDD 60 mg) to oral oxymorphone. Using an equianalgesic ratio of 10 mg IV morphine = 10 mg oral oxymorphone, and applying a 50% cross-tolerance reduction, what is the new daily dose of oxymorphone?
3. A patient with chronic back pain is prescribed a fentanyl 50 mcg/hr patch. The patient develops a fever of 103°F. What is the primary safety concern regarding the fentanyl patch in this clinical situation?

4. A patient is taking MS Contin 100 mg PO Q12H. The physician wants to switch to hydromorphone PO Q6H. Using the ratio 30 mg oral morphine = 7.5 mg oral hydromorphone and a 25% cross-tolerance reduction, what dose should be administered every 6 hours?
5. Which of the following NSAIDs should be avoided in a patient with a documented sulfonamide allergy: Celecoxib, Naproxen, Meloxicam, or Etodolac?
6. A patient is receiving a PCA (Patient-Controlled Analgesia) with morphine. The settings are: Basal rate 1 mg/hr, Demand dose 1 mg, Lockout 10 minutes. If the patient pushes the button 8 times in one hour, what is the maximum amount of morphine they could receive in that hour?
7. A patient with end-stage renal disease (ESRD) requires pain management for a fracture. Which opioid is generally preferred due to the lack of active metabolites that accumulate in renal failure: Morphine, Meperidine, Hydromorphone, or Fentanyl?
8. A patient is currently on a high dose of methadone for opioid use disorder. They are started on ciprofloxacin for a urinary tract infection. What specific monitoring is required due to this combination?
9. Calculate the Morphine Milligram Equivalents (MME) per day for a patient taking hydrocodone/acetaminophen 10/325 mg, two tablets every 6 hours. (Conversion factor for hydrocodone is 1).
10. A patient experiences severe itching and a mild rash after receiving IV morphine. This is determined to be a pseudoallergy. Which opioid class would be the safest to switch to: Phenanthrenes, Phenylpiperidines, or Diphenylheptanes?

Answers & Explanations

1. Answer: 180 mg. Calculation: OxyContin 60 mg Q12H = 120 mg. Breakthrough oxycodone 15 mg × 4 = 60 mg. Total = 120 + 60 = 180 mg oxycodone daily.
2. Answer: 30 mg. Calculation: The ratio is 1:1 for IV morphine to oral oxymorphone. TDD is 60 mg. Apply 50% reduction: $$60 \text{ mg} \times 0.5 = 30 \text{ mg/day}$$.
3. Answer: Increased absorption/toxicity. Heat (including fever or external heat sources) increases the release of fentanyl from the reservoir or matrix, potentially leading to fatal respiratory depression.
4. Answer: 9.375 mg (or 9.4 mg). Calculation: TDD Morphine = 200 mg. Hydromorphone equivalent: $$(200 / 30) \times 7.5 = 50 \text{ mg}$$. Reduce by 25%: $$50 \times 0.75 = 37.5 \text{ mg/day}$$. Divide into Q6H (4 doses): $$37.5 / 4 = 9.375 \text{ mg}$$.
5. Answer: Celecoxib. Celecoxib contains a sulfonamide moiety and is contraindicated in patients with a sulfonamide allergy.
6. Answer: 7 mg. Calculation: Basal rate = 1 mg. Max demand doses per hour = 60 min / 10 min lockout = 6 doses. Even if the patient pushes 8 times, the machine only delivers 6. Total = 1 mg (basal) + 6 mg (demand) = 7 mg.
7. Answer: Fentanyl. Fentanyl is primarily metabolized to inactive metabolites, making it safer in ESRD. Morphine and hydromorphone have metabolites (M6G, H3G) that accumulate and cause neurotoxicity. Meperidine's metabolite (normeperidine) is highly toxic.
8. Answer: ECG (QTc interval). Both methadone and fluoroquinolones like ciprofloxacin can prolong the QTc interval, increasing the risk of Torsades de Pointes.
9. Answer: 80 MME. Calculation: 2 tabs Q6H = 8 tabs/day. 8 tabs × 10 mg hydrocodone = 80 mg hydrocodone. Since the MME factor for hydrocodone is 1, the total is 80 MME.
10. Answer: Phenylpiperidines (e.g., Fentanyl). Morphine is a phenanthrene and causes histamine release (pseudoallergy). Switching to a different chemical class like phenylpiperidines or diphenylheptanes (methadone) reduces the risk of cross-reactivity.

1. Which of the following is the correct IV to PO conversion ratio for morphine?

• A1:1
• B1:2
• C1:3
• D1:5

Frequently Asked Questions

What is the 25-50% dose reduction rule in opioid conversion?

When switching a patient from one opioid to another, clinicians reduce the calculated equivalent dose by 25% to 50% to account for incomplete cross-tolerance. This safety margin prevents over-sedation or respiratory depression because the patient may be more sensitive to the new opioid's effects than the previous one.

How is the MME (Morphine Milligram Equivalent) used in practice?

MME is a standardized value used to compare the potency of different opioids to morphine, helping clinicians identify patients at high risk for overdose. According to HHS guidelines, doses exceeding 50 MME/day warrant increased monitoring and consideration for naloxone prescription.

Can fentanyl patches be used for acute pain management?

No, fentanyl patches are strictly indicated for opioid-tolerant patients with chronic, stable pain because they have a slow onset of action and long half-life. Using them in opioid-naive patients or for acute pain can lead to fatal respiratory depression due to the drug's high potency.

What is the difference between an opioid allergy and a pseudoallergy?

A true opioid allergy is an IgE-mediated immune response, while a pseudoallergy is a non-immunologic histamine release common with phenanthrenes like morphine and codeine. Symptoms of pseudoallergy include itching and flushing, which can often be managed with antihistamines or by switching to a different chemical class of opioids.

Why is acetaminophen limited to 4,000 mg per day?

The 4,000 mg daily limit is established to prevent hepatotoxicity, as higher doses can overwhelm the liver's metabolic pathways and lead to the accumulation of the toxic metabolite NAPQI. In patients with liver disease or chronic alcohol use, this limit is often further reduced to 2,000-3,000 mg per day.